Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer

  • Published on 03/28/2024
  •  Reading time: 4 min.

Kanchi Patell a , Veronica Lee Mears b , Michael H. Storandt c & Amit Mahipal d,*

a Hematology and Oncology Fellow, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
b GI Oncology Clinical Pharmacist Specialist, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
c Internal Medicine Resident, Mayo Clinic, Rochester, MN, USA
d University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA

CONTACT Amit Mahipal mailto:amit.mahipal@uhhospitals.org Seidman Cancer Center, Case Western reserve university, 11100 Euclid Avenue, Cleveland, OH 44106, USA

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Oncology

Receive our newsletter to stay up to date with the latest news in Oncology

More articles

From peer-reviewed journals in Oncology